Literature DB >> 9006349

Acetylcholine receptor alpha-subunit isoforms are differentially expressed in thymuses from myasthenic patients.

F Andreetta1, F Baggi, C Antozzi, E Torchiana, P Bernasconi, O Simoncini, F Cornelio, R Mantegazza.   

Abstract

A central role of the thymus in autosensitization to the acetylcholine receptor has been proposed to explain the immunopathogenetic processes in myasthenia gravis (MG). Two isoforms of the alpha-subunit of the acetylcholine receptor are known; they differ by a 25-amino-acid insertion coded by the P3A exon. We investigated the expression of the P3A exon by RNA polymerase chain reaction in fetal and adult human myoblasts and TE671 cells; both isoforms were expressed. Muscle biopsies from patients with MG, Duchenne muscular dystrophy, and polymyositis were also studied and it was again found that both isoforms were expressed, indicating that the P3A exon is not associated with autoimmune, degenerative, and inflammatory muscle diseases. When P3A expression was studied in thymus samples from normal subjects and from thymectomized MG patients, the P3A+ subunit was absent in 75% of patients with involuted thymus and in all patients with thymomas but was present in normal thymuses and in patients with hyperplasia. Differential expression of the alpha-subunit isoforms of the acetylcholine receptor within the thymus may play a role in the immune pathogenesis of MG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006349      PMCID: PMC1858538     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Molecular distinction between fetal and adult forms of muscle acetylcholine receptor.

Authors:  M Mishina; T Takai; K Imoto; M Noda; T Takahashi; S Numa; C Methfessel; B Sakmann
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

2.  Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.

Authors:  T Kirchner; S Tzartos; F Hoppe; B Schalke; H Wekerle; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Authors:  A Melms; B C Schalke; T Kirchner; H K Müller-Hermelink; E Albert; H Wekerle
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 5.  Myasthenia gravis.

Authors:  J Lindstrom; D Shelton; Y Fujii
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

6.  Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-01-07       Impact factor: 47.728

7.  Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells.

Authors:  Y Matsumoto; A Furuya; T Kobayashi; H Tsukagoshi
Journal:  J Neurol Sci       Date:  1986-09       Impact factor: 3.181

8.  Identification of exposed and buried determinants of the membrane-bound acetylcholine receptor from Torpedo californica.

Authors:  S C Froehner
Journal:  Biochemistry       Date:  1981-08-18       Impact factor: 3.162

9.  Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.

Authors:  M Schluep; N Willcox; A Vincent; G K Dhoot; J Newsom-Davis
Journal:  Ann Neurol       Date:  1987-08       Impact factor: 10.422

10.  Acetylcholine receptor alpha-subunit and myogenin mRNAs in thymus and thymomas.

Authors:  M J Kornstein; O Asher; S Fuchs
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

View more
  2 in total

1.  hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.

Authors:  Akio Masuda; Xin-Ming Shen; Mikako Ito; Tohru Matsuura; Andrew G Engel; Kinji Ohno
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

2.  HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA.

Authors:  Mohammad Alinoor Rahman; Akio Masuda; Kenji Ohe; Mikako Ito; David O Hutchinson; Akila Mayeda; Andrew G Engel; Kinji Ohno
Journal:  Sci Rep       Date:  2013-10-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.